Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5040
-0.0150 ( -2.89% ) N/A
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5040
Previous close
$0.5190
Volume
N/A
Market cap
$82.37M
Day range
$0.5190 - $0.5190
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Sep 11, 2024 |
| 4 | Insider transactions | 1 | Aug 27, 2024 |
| 10-q/a | Quarterly Reports | 77 | Aug 20, 2024 |
| 8-k | 8K-related | 13 | Aug 19, 2024 |
| 4/a | Other | 1 | Aug 16, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4/a | Other | 1 | Jul 19, 2024 |
| 4/a | Other | 1 | Jul 19, 2024 |
| 4 | Insider transactions | 1 | Jul 19, 2024 |
| 4 | Insider transactions | 1 | Jul 17, 2024 |